Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy
Steg, Philippe Gabriel, MD, Mehta, Shamir R., MD, MSc, Pollack, Charles V., MD, Bode, Christoph, MD, Gaudin, Christophe, MD, Fanouillere, Karen, MSc, Moryusef, Angele, MD, Wiviott, Stephen D., MD, Sabatine, Marc S., MD, MPH
Published in The American heart journal (01.12.2012)
Published in The American heart journal (01.12.2012)
Get full text
Journal Article
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Schwartz, Gregory G., MD, PhD, Bessac, Laurence, MD, Berdan, Lisa G., PA, MHS, Bhatt, Deepak L., MD, MPH, Bittner, Vera, MD, Diaz, Rafael, MD, Goodman, Shaun G., MD, MSc, Hanotin, Corinne, MD, Harrington, Robert A., MD, Jukema, J. Wouter, MD, PhD, Mahaffey, Kenneth W., MD, Moryusef, Angèle, MD, Pordy, Robert, MD, Roe, Matthew T., MD, MPH, Rorick, Tyrus, RN, Sasiela, William J., PhD, Shirodaria, Cheerag, MBBS, Szarek, Michael, PhD, Tamby, Jean-François, MD, Tricoci, Pierluigi, MD, White, Harvey, MBBS, DSc, Zeiher, Andreas, MD, Steg, Philippe Gabriel, MD
Published in The American heart journal (01.11.2014)
Published in The American heart journal (01.11.2014)
Get full text
Journal Article